Oman Journal of Ophthalmology

: 2013  |  Volume : 6  |  Issue : 2  |  Page : 127--128

Posterior sub-Tenon's triamcinolone in choroidal granuloma due to probable ocular sarcoidosis

Vinod Kumar, Tinu Gupta, Shivani Jain, Bhuvan Chanana 
 Department of Ophthalmology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, New Delhi, India

Correspondence Address:
Vinod Kumar
57, Sadar Apartments, Mayur Vihar Phase 1, New Delhi - 110 095

How to cite this article:
Kumar V, Gupta T, Jain S, Chanana B. Posterior sub-Tenon's triamcinolone in choroidal granuloma due to probable ocular sarcoidosis.Oman J Ophthalmol 2013;6:127-128

How to cite this URL:
Kumar V, Gupta T, Jain S, Chanana B. Posterior sub-Tenon's triamcinolone in choroidal granuloma due to probable ocular sarcoidosis. Oman J Ophthalmol [serial online] 2013 [cited 2023 Feb 8 ];6:127-128
Available from:

Full Text

A 35-year-old female presented with painless decreased vision OD (20/1200). There were mutton fat keratic precipitates and 4+ cells in the anterior chamber. Fundus showed a solitary choroidal granuloma temporally at the macula, disc edema [Figure 1]a and b and vitreous snowballs inferiorly [Figure 1]c. Spectral-domain optical coherence tomography (OCT) demonstrated choroidal elevation with intraretinal [Figure 1]d and subretinal fluid.Ultrasound B scan confirmed the presence of choroidal granuloma. The left eye was unremarkable (20/20).{Figure 1}

Detailed systemic work up revealed raised erythrocyte sedimentation rate (ESR), raised angiotensin-converting enzyme (ACE) and serum calcium levels. Mantoux was nonreactive; chest X-ray showed no lymphadenopathy. With a diagnosis of probable ocular sarcoidosis [1] , 40 mg (1 ml) of posterior sub-Tenon's triamcinolone acetonide (TA) was administered in the right eye alongwith topical steroids and cycloplegic agents. Best corrected visual acuity (BCVA) improved to 20/200 at three weeks and 20/30 at six weeks following the injection with dramatic resolution of fundus and SD-OCT features [Figure 2] and [Figure 3]. Retinal pigment epithelial changes persisted temporal to the fovea, however there was excellent restoration of the macular architecture on SD-OCT. There was no recurrence till eight months follow-up. The patient was referred to a physician for further evaluation for sarcoidosis.{Figure 2}{Figure 3}


The estimated incidence of ocular involvement in systemic sarcoidosis is 25-80%. [2],[3] While anterior segment involvement occurs in the form of granulomatous uveitis, posterior segment involvement encompasses vitritis, retinal vasculitis, chorioetinitis and granulomas involving choroid, optic nerve and retina. Posterior segment involvement is seen in up to 14-28% of patients with ocular sarcoidosis. [4],[5] The international workshop on ocular sarcoidosis (IOWS) recently laid down the criteria for diagnosis of ocular sarcoidosis [1] Since trans-bronchial lung biopsy required for the definitive diagnosis of sarcoidosis may not be possible in all suspected cases, four diagnostic categories of sarcoid uveitis were described. [1] Based on these criteria we made a diagnosis of probable ocular sarcoidosis.

The use of systemic steroids has been found to be effective in the setting of choroidal granulomas. [6] However since the ocular involvement was unilateral in the present patient, we administered posterior subtenon Triamcinolone Acetonide as it avoids the potential systemic side effects of the drug. This resulted in excellent resolution of ocular lesions and restoration of visual acuity. The use of posterior subtenon TA has been rarely described in posterior uveitis in ocular sarcoidosis. [7] While the risk of systemic side effects is minimal with this route of steroid administration, some local side effects may occur, the most common being rise in intraocular pressure. Rarely, globe perforation has been reported. [8] The choice of treatment should therefore be tailored according to each patient. To conclude, periocular administration of steroids in the form of posterior subtenon injection is a viable and effective option in choroidal granulomas due to ocular sarcoidosis. It allows a high concentration of the drug to be delivered to the posterior segment via trans scleral absorption, with minimal systemic side effects.


1Herbort CP, Rao NA, Mochizuki M; members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop On Ocular Sarcoidosis (IWOS). OculImmunolInflamm 2009;17:160-9.
2Bonfioli AA, Orefice F. Sarcoidosis. Semin Ophthalmol 2005;20:177-82.
3Weber M. Eye and sarcoidosis. Rev Prat 1999;49:2004-7.
4Kawaguchi T, Hanada A, Horie S, Sugamoto Y, Sugita S, Mochizuki M. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol 2007;51:121-6.
5Dufay-Dupar B, Soubrane G, Ortonne N. Choroidal white dots and sarcoidosis. J Fr Ophtalmol 2006;29:e23.
6Desai UR, Tawansy KA, Joondeph BC, Schiffman RM. Choroidal granulomas in systemic sarcoidosis. Retina 2001; 21:40-7.
7Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP. Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: Indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 1999;237:289-95.
8Kuo HK, Lai IC, Gang PC, Teng MC. Ocular complications after a subtenon injection of Triamcinolone Acetonide for uveitis. Chang Gunj Med J 2005;28:85.